Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates
- PMID: 39833641
- PMCID: PMC11746986
- DOI: 10.1007/s44197-025-00346-5
Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates
Abstract
Background: A substantial subset of individuals recovering from the Coronavirus disease 2019 (COVID-19) continues to experience persistent symptoms. Individuals with type 2 diabetes face increased morbidity and mortality following COVID-19 infection. This study aimed to identify risk factors for developing post-COVID-19 conditions among COVID-19 patients with diabetes compared to those without diabetes in the United Arab Emirates.
Methods: A retrospective study was conducted on a random sample of 400 patients with confirmed COVID-19 (n = 200/400 patients with diabetes versus n = 200 patients without diabetes). Participants were invited to a telephone interview to assess post-COVID-19 symptoms persisting for at least three months after their initial positive COVID-19 polymerase chain reaction (PCR) test. A total of 167 hospitalized patients participated, including 89 with pre-existing diabetes and 78 without diabetes.
Results: The prevalence of self-reported post-COVID-19 conditions among participants with diabetes was 34.9%, compared to 14.1% among those without diabetes. Patients with diabetes reported a significant decline in functional status post-COVID-19, with 34.8% experiencing impaired physical activity and 32.6% reporting pain and discomfort, compared to 15.4% and 11.5%, respectively, among participants without diabetes. Older age and female gender were associated with a higher prevalence of post-COVID-19 conditions in the diabetes group.
Conclusion: Patients with diabetes in this study self-reported a higher frequency and severity of post-COVID-19 conditions compared to those without diabetes. Risk factors predisposing to severe post-COVID-19 conditions included female gender, older age, and comorbidities. Self-reported depression was rare in both groups of this cohort.
Keywords: Diabetes type 2; Post-COVID-19 conditions; Prevalence; Risk factors; UAE.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of Interest: The authors declare no conflict of interest. Informed Consent Statement: Informed consent of participants was considered through their certified acceptance as consent to participate in the study. Institutional Review Board Statement: The study protocol was approved by the Clinical Research Department-Tawam Hospital and the Department of Health Abu Dhabi Health Research and Technology Ethics Committee (Ref: DOH/CVDC/2022/245).
References
-
- Centers for Disease Control and Prevention. Post-COVID conditions: healthcare providers. 2022. Accessed: October 10, 2022. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-c...
-
- World Health Organization. A clinical case definition of post-COVID-19 condition by a Delphi consensus. 2021. Licence: CC BY-NC-SA 3.0 IGO. WHO reference number: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1
-
- Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID-19. Sci Immunol 2020;5:eabe8063. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
